Skip to content

Sanara MedTech Inc. SMTI Equity Investment

Equity Investment at other companies

KG
King PharmaceuticalsKG
$33.54M
Kopin logo
KopinKOPN
$3.4M+21.4%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$351.38M+807%
Nextra Energy logo
Nextra EnergyNEE
$662M-1.3%
Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$24.1M+35.4%
AT&T logo
AT&TT
$1.11B+17.6%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept SMTI:EquityInvestment.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s equity investment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s equity investment?
Sanara MedTech Inc. (SMTI) reported equity investment of $9M in Q3 2025.
What does equity investment mean?
This represents the carrying value of equity investments held in other entities that do not qualify for consolidation or the equity method of accounting. It reflects the company's strategic minority interests or non-controlling stakes in external businesses. Investors monitor this to assess the value of the company's portfolio of strategic partnerships and external investments.